Peter J. Grob

1.2k total citations
38 papers, 944 citations indexed

About

Peter J. Grob is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Peter J. Grob has authored 38 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Virology and 11 papers in Epidemiology. Recurrent topics in Peter J. Grob's work include HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (10 papers) and HIV/AIDS drug development and treatment (7 papers). Peter J. Grob is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (10 papers) and HIV/AIDS drug development and treatment (7 papers). Peter J. Grob collaborates with scholars based in Switzerland, Denmark and Germany. Peter J. Grob's co-authors include Theodor Inderbitzin, Milos Opravil, Helen I. Joller‐Jemelka, Leslie R. Bisset, Andreas Wicki, Madeleine Rothen, Richard W. Cone, Jürg Böni, Jörg Schüpbach and Walter Fierz and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

Peter J. Grob

36 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Grob Switzerland 18 370 353 318 208 196 38 944
O Picard France 20 490 1.3× 303 0.9× 250 0.8× 185 0.9× 182 0.9× 48 1.1k
Marcello Mazzetti Italy 12 447 1.2× 415 1.2× 193 0.6× 355 1.7× 490 2.5× 22 1.2k
F. Bouscarat France 14 339 0.9× 226 0.6× 183 0.6× 42 0.2× 193 1.0× 65 836
J.M. Huraux France 11 270 0.7× 138 0.4× 229 0.7× 90 0.4× 79 0.4× 33 631
D E Lewis United States 20 425 1.1× 474 1.3× 409 1.3× 64 0.3× 509 2.6× 32 1.5k
C. Pedersen Denmark 12 235 0.6× 297 0.8× 348 1.1× 74 0.4× 72 0.4× 28 786
Betsey Herpin United States 12 224 0.6× 591 1.7× 330 1.0× 83 0.4× 417 2.1× 17 931
Patricia Price Australia 21 842 2.3× 404 1.1× 440 1.4× 128 0.6× 444 2.3× 52 1.5k
Patricia Baré Argentina 16 228 0.6× 172 0.5× 198 0.6× 226 1.1× 173 0.9× 46 665
Debbie van Baarle Netherlands 21 541 1.5× 304 0.9× 302 0.9× 158 0.8× 644 3.3× 47 1.3k

Countries citing papers authored by Peter J. Grob

Since Specialization
Citations

This map shows the geographic impact of Peter J. Grob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Grob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Grob more than expected).

Fields of papers citing papers by Peter J. Grob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Grob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Grob. The network helps show where Peter J. Grob may publish in the future.

Co-authorship network of co-authors of Peter J. Grob

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Grob. A scholar is included among the top collaborators of Peter J. Grob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Grob. Peter J. Grob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somaini, Bertino & Peter J. Grob. (2012). How and why AIDS changed drug policy in Switzerland. Journal of Public Health Policy. 33(3). 317–324. 6 indexed citations
2.
Csete, Joanne & Peter J. Grob. (2011). Switzerland, HIV and the power of pragmatism: Lessons for drug policy development. International Journal of Drug Policy. 23(1). 82–86. 19 indexed citations
3.
Hutin, Yvan, Mary Ellen Kitler, Gregory J. Dore, et al.. (2004). Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group. 69 indexed citations
4.
Willers, Jörg, Eva Niederer, Elisabeth Ludwig, et al.. (2002). The use of anti‐T‐cell receptor‐Vβ antibodies for the estimation of treatment success and phenotypic characterization of clonal T‐cell populations in cutaneous T‐cell lymphomas. British Journal of Haematology. 118(4). 1019–1026. 34 indexed citations
5.
Bisset, Leslie R., Richard W. Cone, Marek Fischer, et al.. (2001). Long-Term Evaluation of T-Cell Subset Changes After Effective Combination Antiretroviral Therapy During Asymptomatic HIV-Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 27(3). 266–271. 4 indexed citations
6.
Dummer, Reinhard, Frank O. Nestlé, Eva Niederer, et al.. (1999). Genotypic, phenotypic and functional analysis of CD4 + CD7 + and CD4 + CD7 - T lymphocyte subsets in Sézary syndrome. Archives of Dermatological Research. 291(6). 307–311. 36 indexed citations
7.
Böni, Jürg, Martin Gebhardt, Luc Perrin, et al.. (1999). High Frequency of Non-B Subtypes in Newly Diagnosed HIV-1 Infections in Switzerland. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(2). 174–174. 70 indexed citations
8.
Goebel, Frank-D., Josef W. Mannhalter, Robert B. Belshe, et al.. (1999). Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. AIDS. 13(12). 1461–1468. 24 indexed citations
9.
Bisset, Leslie R., Richard W. Cone, Werner Huber, et al.. (1998). Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. AIDS. 12(16). 2115–2123. 88 indexed citations
11.
Böni, Jürg, Milos Opravil, Zuzana Tomasik, et al.. (1997). Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS. 11(6). F47–F52. 72 indexed citations
12.
Grob, Peter J., et al.. (1996). Einfache Schulversuche zur Lebensmittelchemie.
13.
Joller‐Jemelka, Helen I., Andreas Wicki, & Peter J. Grob. (1994). Detection of HBs antigen in “anti-HBc alone” positive sera. Journal of Hepatology. 21(2). 269–272. 63 indexed citations
14.
Kägi, Martin, Walter Fierz, Peter J. Grob, & Erich W. Russi. (1993). High Proportion of Gamma-Delta T Cell Receptor Positive T Cells in Bronchoalveolar Lavage and Peripheral Blood of HIV-lnfected Patients with <i>Pneumocystis carinii</i> Pneumonias. Respiration. 60(3). 170–177. 14 indexed citations
15.
Aubert, Vincent, Peter Erb, Luc Perrin, Peter J. Grob, & P. C. Frei. (1991). Evaluation of Commercial Rapid Tests for Serological Determination of HIV Infection. Laboratory Medicine. 22(12). 869–872. 4 indexed citations
16.
Howe, Jörg, E. Strobel, Friedrich Deinhardt, et al.. (1988). A new second-generation anti-HIV-1 enzyme immunoassay using recombinant envelope and core proteins. AIDS. 2(6). 477–480. 6 indexed citations
17.
Pirovino, M, et al.. (1984). Pneumococcal Vaccination: The Response of Patients with Alcoholic Liver Cirrhosis. Hepatology. 4(5). 946–949. 33 indexed citations
18.
Altorfer, J, Gert Frösner, M Pirovino, et al.. (1983). Prevalence and Significance of Anti-HBc IgM (Radioimmunoassay) in Acute and Chronic Hepatitis B and in Blood Donors†. Hepatology. 3(3). 337–342. 43 indexed citations
19.
Just, M, et al.. (1973). CIRCULATING INTERFERON AFTER TRANSFER-FACTOR THERAPY. The Lancet. 302(7842). 1382–1382. 16 indexed citations
20.
Grob, Peter J., et al.. (1971). B1 A and SH Antigen in Chronic Hepatitis. Gastroenterology. 61(1). 91–95. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026